Introduction Current pharmacological treatment options for hyperemesis gravidarum have been introduced based on scarce evidence and are often not sufficiently effective. Several case reports suggest ...

Do you know of any cases of the drug Zofran (ondansetron) being used to treat bulimia in South Africa? The drug was originally used for patients undergoing chemotherapy but in about 2000 clinical ...

Ondansetron may not be safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine whether you should take the ...

Ondansetron oral tablet is a generic drug that’s prescribed for nausea and vomiting in certain situations. Ondansetron has interactions with some other drugs and supplements, including certain ...

On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been ...

Oral ondansetron increases the risk of sudden cardiac death among patients receiving maintenance hemodialysis, a new study finds. In a study of 119,254 patients in the 2012-2019 US Renal Data ...

(2024-02-27 | NYSEAM:CHRO) Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions ...

--Benuvia Operations, LLC, a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp.,, a pioneer in the development of non-opioid pain treatment therapeutics, are pleased to ...

AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. (“Chromocell”), (NYSE ...

AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. (“Chromocell”), (NYSE ...

AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. (“Chromocell”), (NYSE American: CHRO), a ...